Tom Kovesi

Investigator, CHEO Research Institute

Dr. Kovesi is a pediatric respirologist at CHEO, and Professor of Pediatrics at the University of Ottawa. He completed his residency training at CHEO and at the Izaak Walton Killam children’s hospital in Halifax. He completed his fellowship at Sick Kids, in Toronto. Dr. Kovesi has been on staff at CHEO since 1992. Dr. Kovesi’s work has included the development of Canadian national asthma guidelines, description of the respiratory complications of congenital tracheoesophageal fistula, and research on the effects of problems with indoor air quality on the respiratory health of indigenous children, including Inuit children and First Nations children living on reserves in Canada.

The latter is his primary research focus, and his research group has published the most comprehensive descriptions of indoor air quality in houses in Nunavut and First Nations reserves in northern Ontario available, as well as one of the largest RCT’s on modifying indoor air quality in the world. Dr. Kovesi has served as Chair of the Ontario Thoracic Society, Chair of the Pediatric Assembly of the Canadian Thoracic Society, Chief Examiner for Pediatric Respirology, Royal College of Physicians and Surgeons of Canada, and Anglophone Content Expert (Respirology), Unit 1, Faculty of Medicine, University of Ottawa. He is a member of the Executive, International Network on Esophageal Atresia.

Related News

Research Projects

  1. Housing conditions and respiratory morbidity in Indigenous children in remote communities in Northwestern Ontario, Canada


    Many houses in these FN communities had substantial IEQ problems. Presence of endotoxin was associated with wheezing with colds and tended to be associated with LRTI in young children. Surface area of visible mould tended to be associated with URTI visits. Urgent collective action is needed to respond to historically damaging impacts of colonization, including systemic indifference.

  2. Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic


    Although a subset of aerosol samples exhibited detectable SARS-CoV-2 RNA at low titres, the presence of viable SARS-CoV-2 virus in aerosols appears to be infrequent at >2m distance.

  3. Care recommendations for the respiratory complications of esophageal atresia-tracheoesophageal fistula


    Tracheoesophageal fistula (TEF) with esophageal atresia (EA) is a common congenital anomaly that is associated with significant respiratory morbidity throughout life. The objective of this document is to provide a framework for the diagnosis and management of the respiratory complications that are associated with the condition.

  4. Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children


    The intent of this review is to draw attention to this important entity and to allow the reader to create an informed and practical approach to the management of their patients at risk.

  5. Oral aspiration, type 1 laryngeal cleft, and respiratory tract infections in canadian inuit children


    We conclude that swallowing dysfunction is not only prevalent amongst Canadian Inuit but clinically significant. This is the first study to demonstrate an association between swallowing dysfunction and respiratory morbidity in this population.